Do you have doubts about how to establish percentages for impurities or degradation products?
We can help by answering your questions and in the event that data is required to establish these limits, we can also help to generate this data through in silico studies and thus correct the final specification in a drug for one or more degradation compounds or impurities according to the ICH Q6 guideline.